Consensus Enovis Corporation

Stocks

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 21:00:02 23/10/2026 BST			5-day change	1st Jan Change
21.08 ^USD	-2.36%		+7.61%	-20.87%

10-12	Needham Cuts Price Target on Enovis to $34 From $52, Keeps Buy Rating	MT
10-05	BofA Securities Adjusts Enovis Price Target to $44 From $51, Maintains Buy Rating	MT

Evolution of the Average Target: Enovis Corporation

Evolution of the Target Price: Enovis Corporation

Changes in Analyst Recommendations: Enovis Corporation

db25d610ce3a4ded2c71a62fa18577.nbou4Df-eU46XvgNt63eKUD_k9Li6XO51RJNhi0oh6I.99x_gkShEwRcb49P55npcXnG16a93kfDlFEdznQFyer5y22YT40JI20LoQ~d1dc09d9ea27d89be2d4ea489ef3990d

Analysts' recommendations: Enovis Corporation

10-12	Needham Cuts Price Target on Enovis to $34 From $52, Keeps Buy Rating	MT
10-05	BofA Securities Adjusts Enovis Price Target to $44 From $51, Maintains Buy Rating	MT
09-01	BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating	MT
07-28	UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating	MT
07-09	BMO Capital Initiates Enovis at Outperform With $29 Price Target	MT
02-27	Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating	MT
01-06	BTIG Initiates Enovis at Buy With $41 Price Target	MT
08/08/25	Needham Cuts Price Target on Enovis to $49 From $57, Keeps Buy Rating	MT
08/08/25	UBS Adjusts Enovis Price Target to $57 From $65, Maintains Buy Rating	MT
12/05/25	UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating	MT
03/10/24	JMP Securities Initiates Enovis at Outperform With $62 Price Target	MT
08/08/24	Needham Adjusts Price Target on Enovis to $65 From $82, Maintains Buy Rating	MT
13/06/24	JPMorgan Initiates Enovis at Neutral With $53 Price Target	MT
23/02/24	Canaccord Genuity Ups Price Target on Enovis to $75 From $73, Maintains Buy Rating	MT
23/02/24	Needham Raises Price Target on Enovis to $82 From $73, Maintains Buy Rating	MT
13/02/24	Stephens Initiates Enovis With Overweight Rating, $72 Price Target	MT
22/01/24	UBS Initiates Coverage on Enovis With Buy Rating, $75 Price Target	MT
03/01/24	William Blair Initiates Enovis at Outperform Rating	MT
20/12/23	Canaccord Genuity Adjusts Enovis Price Target to $71 From $65, Maintains Buy Rating	MT
15/12/23	Needham Adjusts Price Target on Enovis to $70 From $62, Keeps Buy Rating	MT
04/08/23	Baird Adjusts Price Target on Enovis to $70 From $67, Maintains Outperform Rating	MT
26/06/23	Needham Initiates Enovis With Buy Rating, $70 Price Target	MT
12/05/23	Wells Fargo Upgrades Enovis to Overweight Rating From Equal Weight, Adjusts Price Target to $67 From $55	MT
24/02/23	Baird Adjusts Enovis Price Target to $64 From $68, Maintains Outperform Rating	MT
03/11/22	Baird Adjusts Enovis' Price Target to $68 From $73, Keeps Outperform Rating	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ENOVIS CORPORATION					+71.17%
	ABBOTT LABORATORIES					+14.29%
	STRYKER CORPORATION					+18.06%
	MEDTRONIC PLC					+9.65%
	ESSILORLUXOTTICA					+19.16%
	CENCORA, INC.					+11.51%
	HOYA CORPORATION					+17.34%
	BECTON, DICKINSON AND COMPANY					-1.68%
	IDEXX LABORATORIES, INC.					+24.56%
	ALCON INC.					+29.2%
	Average					+21.33%
	Weighted average by Cap.					+14.97%